Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops

Summary

Study of the safety, tolerability and pharmacokinetic profile of different doses of SYL1801 eye drops in healthy volunteers.

Timeline

Start

2021-03-17

Primary completion

2021-12-21

Completion

2021-12-21

Outcome

Met primary endpoint

release “This study provides evidence that SYL1801 is safe and well tolerated; therefore, the Phase I has met the primary safety endpoint.” pharmamar.com ↗

Drugs

Indications